COVID-19 Impact on Global Epithelial Stem Cells Market Size, Status and Forecast 2020-2026

September 2020 | 127 pages | ID: C35A6E133166EN
QYResearch

Abstracts

This report focuses on the global Epithelial Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epithelial Stem Cells development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• 3Dmatrix
• Aldagen
• Hybrid Organ
• Intellicell Biosciences
• Athersys
• Beike Biotechnology
• Biotime
• Brainstorm Cell Therapeutics
• Gamida Cell
• Capricor
• Cellerant Therapeutics
• Globalstem
• Cellular Dyna
• International Stem Cell
• Juventas Therapeutics
• Mesoblast
• Neuralstem
• Neurogeneration
• Ocata

Market segment by Type, the product can be split into

• Absorptive Cells
• Goblet Cell
• Paneth Cells
• Oligodendrocytes

Market segment by Application, split into

• Tissue Repair Damage
• Autoimmune Diseases
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Epithelial Stem Cells status, future forecast, growth opportunity, key market and key players.
• To present the Epithelial Stem Cells development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Epithelial Stem Cells are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epithelial Stem Cells Revenue
1.4 Market Analysis by Type
  1.4.1 Global Epithelial Stem Cells Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Absorptive Cells
  1.4.3 Goblet Cell
  1.4.4 Paneth Cells
  1.4.5 Oligodendrocytes
1.5 Market by Application
  1.5.1 Global Epithelial Stem Cells Market Share by Application: 2020 VS 2026
  1.5.2 Tissue Repair Damage
  1.5.3 Autoimmune Diseases
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Epithelial Stem Cells Industry Impact
  1.6.1 How the Covid-19 is Affecting the Epithelial Stem Cells Industry
    1.6.1.1 Epithelial Stem Cells Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Epithelial Stem Cells Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Epithelial Stem Cells Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Epithelial Stem Cells Market Perspective (2015-2026)
2.2 Epithelial Stem Cells Growth Trends by Regions
  2.2.1 Epithelial Stem Cells Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Epithelial Stem Cells Historic Market Share by Regions (2015-2020)
  2.2.3 Epithelial Stem Cells Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Epithelial Stem Cells Market Growth Strategy
  2.3.6 Primary Interviews with Key Epithelial Stem Cells Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Epithelial Stem Cells Players by Market Size
  3.1.1 Global Top Epithelial Stem Cells Players by Revenue (2015-2020)
  3.1.2 Global Epithelial Stem Cells Revenue Market Share by Players (2015-2020)
  3.1.3 Global Epithelial Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epithelial Stem Cells Market Concentration Ratio
  3.2.1 Global Epithelial Stem Cells Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Epithelial Stem Cells Revenue in 2019
3.3 Epithelial Stem Cells Key Players Head office and Area Served
3.4 Key Players Epithelial Stem Cells Product Solution and Service
3.5 Date of Enter into Epithelial Stem Cells Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Epithelial Stem Cells Historic Market Size by Type (2015-2020)
4.2 Global Epithelial Stem Cells Forecasted Market Size by Type (2021-2026)

5 EPITHELIAL STEM CELLS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Epithelial Stem Cells Market Size by Application (2015-2020)
5.2 Global Epithelial Stem Cells Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Epithelial Stem Cells Market Size (2015-2020)
6.2 Epithelial Stem Cells Key Players in North America (2019-2020)
6.3 North America Epithelial Stem Cells Market Size by Type (2015-2020)
6.4 North America Epithelial Stem Cells Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Epithelial Stem Cells Market Size (2015-2020)
7.2 Epithelial Stem Cells Key Players in Europe (2019-2020)
7.3 Europe Epithelial Stem Cells Market Size by Type (2015-2020)
7.4 Europe Epithelial Stem Cells Market Size by Application (2015-2020)

8 CHINA

8.1 China Epithelial Stem Cells Market Size (2015-2020)
8.2 Epithelial Stem Cells Key Players in China (2019-2020)
8.3 China Epithelial Stem Cells Market Size by Type (2015-2020)
8.4 China Epithelial Stem Cells Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Epithelial Stem Cells Market Size (2015-2020)
9.2 Epithelial Stem Cells Key Players in Japan (2019-2020)
9.3 Japan Epithelial Stem Cells Market Size by Type (2015-2020)
9.4 Japan Epithelial Stem Cells Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Epithelial Stem Cells Market Size (2015-2020)
10.2 Epithelial Stem Cells Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epithelial Stem Cells Market Size by Type (2015-2020)
10.4 Southeast Asia Epithelial Stem Cells Market Size by Application (2015-2020)

11 INDIA

11.1 India Epithelial Stem Cells Market Size (2015-2020)
11.2 Epithelial Stem Cells Key Players in India (2019-2020)
11.3 India Epithelial Stem Cells Market Size by Type (2015-2020)
11.4 India Epithelial Stem Cells Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Epithelial Stem Cells Market Size (2015-2020)
12.2 Epithelial Stem Cells Key Players in Central & South America (2019-2020)
12.3 Central & South America Epithelial Stem Cells Market Size by Type (2015-2020)
12.4 Central & South America Epithelial Stem Cells Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 3Dmatrix
  13.1.1 3Dmatrix Company Details
  13.1.2 3Dmatrix Business Overview and Its Total Revenue
  13.1.3 3Dmatrix Epithelial Stem Cells Introduction
  13.1.4 3Dmatrix Revenue in Epithelial Stem Cells Business (2015-2020))
  13.1.5 3Dmatrix Recent Development
13.2 Aldagen
  13.2.1 Aldagen Company Details
  13.2.2 Aldagen Business Overview and Its Total Revenue
  13.2.3 Aldagen Epithelial Stem Cells Introduction
  13.2.4 Aldagen Revenue in Epithelial Stem Cells Business (2015-2020)
  13.2.5 Aldagen Recent Development
13.3 Hybrid Organ
  13.3.1 Hybrid Organ Company Details
  13.3.2 Hybrid Organ Business Overview and Its Total Revenue
  13.3.3 Hybrid Organ Epithelial Stem Cells Introduction
  13.3.4 Hybrid Organ Revenue in Epithelial Stem Cells Business (2015-2020)
  13.3.5 Hybrid Organ Recent Development
13.4 Intellicell Biosciences
  13.4.1 Intellicell Biosciences Company Details
  13.4.2 Intellicell Biosciences Business Overview and Its Total Revenue
  13.4.3 Intellicell Biosciences Epithelial Stem Cells Introduction
  13.4.4 Intellicell Biosciences Revenue in Epithelial Stem Cells Business (2015-2020)
  13.4.5 Intellicell Biosciences Recent Development
13.5 Athersys
  13.5.1 Athersys Company Details
  13.5.2 Athersys Business Overview and Its Total Revenue
  13.5.3 Athersys Epithelial Stem Cells Introduction
  13.5.4 Athersys Revenue in Epithelial Stem Cells Business (2015-2020)
  13.5.5 Athersys Recent Development
13.6 Beike Biotechnology
  13.6.1 Beike Biotechnology Company Details
  13.6.2 Beike Biotechnology Business Overview and Its Total Revenue
  13.6.3 Beike Biotechnology Epithelial Stem Cells Introduction
  13.6.4 Beike Biotechnology Revenue in Epithelial Stem Cells Business (2015-2020)
  13.6.5 Beike Biotechnology Recent Development
13.7 Biotime
  13.7.1 Biotime Company Details
  13.7.2 Biotime Business Overview and Its Total Revenue
  13.7.3 Biotime Epithelial Stem Cells Introduction
  13.7.4 Biotime Revenue in Epithelial Stem Cells Business (2015-2020)
  13.7.5 Biotime Recent Development
13.8 Brainstorm Cell Therapeutics
  13.8.1 Brainstorm Cell Therapeutics Company Details
  13.8.2 Brainstorm Cell Therapeutics Business Overview and Its Total Revenue
  13.8.3 Brainstorm Cell Therapeutics Epithelial Stem Cells Introduction
  13.8.4 Brainstorm Cell Therapeutics Revenue in Epithelial Stem Cells Business (2015-2020)
  13.8.5 Brainstorm Cell Therapeutics Recent Development
13.9 Gamida Cell
  13.9.1 Gamida Cell Company Details
  13.9.2 Gamida Cell Business Overview and Its Total Revenue
  13.9.3 Gamida Cell Epithelial Stem Cells Introduction
  13.9.4 Gamida Cell Revenue in Epithelial Stem Cells Business (2015-2020)
  13.9.5 Gamida Cell Recent Development
13.10 Capricor
  13.10.1 Capricor Company Details
  13.10.2 Capricor Business Overview and Its Total Revenue
  13.10.3 Capricor Epithelial Stem Cells Introduction
  13.10.4 Capricor Revenue in Epithelial Stem Cells Business (2015-2020)
  13.10.5 Capricor Recent Development
13.11 Cellerant Therapeutics
  10.11.1 Cellerant Therapeutics Company Details
  10.11.2 Cellerant Therapeutics Business Overview and Its Total Revenue
  10.11.3 Cellerant Therapeutics Epithelial Stem Cells Introduction
  10.11.4 Cellerant Therapeutics Revenue in Epithelial Stem Cells Business (2015-2020)
  10.11.5 Cellerant Therapeutics Recent Development
13.12 Globalstem
  10.12.1 Globalstem Company Details
  10.12.2 Globalstem Business Overview and Its Total Revenue
  10.12.3 Globalstem Epithelial Stem Cells Introduction
  10.12.4 Globalstem Revenue in Epithelial Stem Cells Business (2015-2020)
  10.12.5 Globalstem Recent Development
13.13 Cellular Dyna
  10.13.1 Cellular Dyna Company Details
  10.13.2 Cellular Dyna Business Overview and Its Total Revenue
  10.13.3 Cellular Dyna Epithelial Stem Cells Introduction
  10.13.4 Cellular Dyna Revenue in Epithelial Stem Cells Business (2015-2020)
  10.13.5 Cellular Dyna Recent Development
13.14 International Stem Cell
  10.14.1 International Stem Cell Company Details
  10.14.2 International Stem Cell Business Overview and Its Total Revenue
  10.14.3 International Stem Cell Epithelial Stem Cells Introduction
  10.14.4 International Stem Cell Revenue in Epithelial Stem Cells Business (2015-2020)
  10.14.5 International Stem Cell Recent Development
13.15 Juventas Therapeutics
  10.15.1 Juventas Therapeutics Company Details
  10.15.2 Juventas Therapeutics Business Overview and Its Total Revenue
  10.15.3 Juventas Therapeutics Epithelial Stem Cells Introduction
  10.15.4 Juventas Therapeutics Revenue in Epithelial Stem Cells Business (2015-2020)
  10.15.5 Juventas Therapeutics Recent Development
13.16 Mesoblast
  10.16.1 Mesoblast Company Details
  10.16.2 Mesoblast Business Overview and Its Total Revenue
  10.16.3 Mesoblast Epithelial Stem Cells Introduction
  10.16.4 Mesoblast Revenue in Epithelial Stem Cells Business (2015-2020)
  10.16.5 Mesoblast Recent Development
13.17 Neuralstem
  10.17.1 Neuralstem Company Details
  10.17.2 Neuralstem Business Overview and Its Total Revenue
  10.17.3 Neuralstem Epithelial Stem Cells Introduction
  10.17.4 Neuralstem Revenue in Epithelial Stem Cells Business (2015-2020)
  10.17.5 Neuralstem Recent Development
13.18 Neurogeneration
  10.18.1 Neurogeneration Company Details
  10.18.2 Neurogeneration Business Overview and Its Total Revenue
  10.18.3 Neurogeneration Epithelial Stem Cells Introduction
  10.18.4 Neurogeneration Revenue in Epithelial Stem Cells Business (2015-2020)
  10.18.5 Neurogeneration Recent Development
13.19 Ocata
  10.19.1 Ocata Company Details
  10.19.2 Ocata Business Overview and Its Total Revenue
  10.19.3 Ocata Epithelial Stem Cells Introduction
  10.19.4 Ocata Revenue in Epithelial Stem Cells Business (2015-2020)
  10.19.5 Ocata Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Epithelial Stem Cells Key Market Segments
Table 2. Key Players Covered: Ranking by Epithelial Stem Cells Revenue
Table 3. Ranking of Global Top Epithelial Stem Cells Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Epithelial Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Absorptive Cells
Table 6. Key Players of Goblet Cell
Table 7. Key Players of Paneth Cells
Table 8. Key Players of Oligodendrocytes
Table 9. COVID-19 Impact Global Market: (Four Epithelial Stem Cells Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Epithelial Stem Cells Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Epithelial Stem Cells Players to Combat Covid-19 Impact
Table 14. Global Epithelial Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Epithelial Stem Cells Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Epithelial Stem Cells Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Epithelial Stem Cells Market Share by Regions (2015-2020)
Table 18. Global Epithelial Stem Cells Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Epithelial Stem Cells Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Epithelial Stem Cells Market Growth Strategy
Table 24. Main Points Interviewed from Key Epithelial Stem Cells Players
Table 25. Global Epithelial Stem Cells Revenue by Players (2015-2020) (Million US$)
Table 26. Global Epithelial Stem Cells Market Share by Players (2015-2020)
Table 27. Global Top Epithelial Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epithelial Stem Cells as of 2019)
Table 28. Global Epithelial Stem Cells by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Epithelial Stem Cells Product Solution and Service
Table 31. Date of Enter into Epithelial Stem Cells Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Epithelial Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 34. Global Epithelial Stem Cells Market Size Share by Type (2015-2020)
Table 35. Global Epithelial Stem Cells Revenue Market Share by Type (2021-2026)
Table 36. Global Epithelial Stem Cells Market Size Share by Application (2015-2020)
Table 37. Global Epithelial Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 38. Global Epithelial Stem Cells Market Size Share by Application (2021-2026)
Table 39. North America Key Players Epithelial Stem Cells Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Epithelial Stem Cells Market Share (2019-2020)
Table 41. North America Epithelial Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 42. North America Epithelial Stem Cells Market Share by Type (2015-2020)
Table 43. North America Epithelial Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 44. North America Epithelial Stem Cells Market Share by Application (2015-2020)
Table 45. Europe Key Players Epithelial Stem Cells Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Epithelial Stem Cells Market Share (2019-2020)
Table 47. Europe Epithelial Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Epithelial Stem Cells Market Share by Type (2015-2020)
Table 49. Europe Epithelial Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Epithelial Stem Cells Market Share by Application (2015-2020)
Table 51. China Key Players Epithelial Stem Cells Revenue (2019-2020) (Million US$)
Table 52. China Key Players Epithelial Stem Cells Market Share (2019-2020)
Table 53. China Epithelial Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 54. China Epithelial Stem Cells Market Share by Type (2015-2020)
Table 55. China Epithelial Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 56. China Epithelial Stem Cells Market Share by Application (2015-2020)
Table 57. Japan Key Players Epithelial Stem Cells Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Epithelial Stem Cells Market Share (2019-2020)
Table 59. Japan Epithelial Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Epithelial Stem Cells Market Share by Type (2015-2020)
Table 61. Japan Epithelial Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Epithelial Stem Cells Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Epithelial Stem Cells Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Epithelial Stem Cells Market Share (2019-2020)
Table 65. Southeast Asia Epithelial Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Epithelial Stem Cells Market Share by Type (2015-2020)
Table 67. Southeast Asia Epithelial Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Epithelial Stem Cells Market Share by Application (2015-2020)
Table 69. India Key Players Epithelial Stem Cells Revenue (2019-2020) (Million US$)
Table 70. India Key Players Epithelial Stem Cells Market Share (2019-2020)
Table 71. India Epithelial Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 72. India Epithelial Stem Cells Market Share by Type (2015-2020)
Table 73. India Epithelial Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 74. India Epithelial Stem Cells Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Epithelial Stem Cells Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Epithelial Stem Cells Market Share (2019-2020)
Table 77. Central & South America Epithelial Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Epithelial Stem Cells Market Share by Type (2015-2020)
Table 79. Central & South America Epithelial Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Epithelial Stem Cells Market Share by Application (2015-2020)
Table 81. 3Dmatrix Company Details
Table 82. 3Dmatrix Business Overview
Table 83. 3Dmatrix Product
Table 84. 3Dmatrix Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 85. 3Dmatrix Recent Development
Table 86. Aldagen Company Details
Table 87. Aldagen Business Overview
Table 88. Aldagen Product
Table 89. Aldagen Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 90. Aldagen Recent Development
Table 91. Hybrid Organ Company Details
Table 92. Hybrid Organ Business Overview
Table 93. Hybrid Organ Product
Table 94. Hybrid Organ Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 95. Hybrid Organ Recent Development
Table 96. Intellicell Biosciences Company Details
Table 97. Intellicell Biosciences Business Overview
Table 98. Intellicell Biosciences Product
Table 99. Intellicell Biosciences Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 100. Intellicell Biosciences Recent Development
Table 101. Athersys Company Details
Table 102. Athersys Business Overview
Table 103. Athersys Product
Table 104. Athersys Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 105. Athersys Recent Development
Table 106. Beike Biotechnology Company Details
Table 107. Beike Biotechnology Business Overview
Table 108. Beike Biotechnology Product
Table 109. Beike Biotechnology Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 110. Beike Biotechnology Recent Development
Table 111. Biotime Company Details
Table 112. Biotime Business Overview
Table 113. Biotime Product
Table 114. Biotime Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 115. Biotime Recent Development
Table 116. Brainstorm Cell Therapeutics Business Overview
Table 117. Brainstorm Cell Therapeutics Product
Table 118. Brainstorm Cell Therapeutics Company Details
Table 119. Brainstorm Cell Therapeutics Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 120. Brainstorm Cell Therapeutics Recent Development
Table 121. Gamida Cell Company Details
Table 122. Gamida Cell Business Overview
Table 123. Gamida Cell Product
Table 124. Gamida Cell Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 125. Gamida Cell Recent Development
Table 126. Capricor Company Details
Table 127. Capricor Business Overview
Table 128. Capricor Product
Table 129. Capricor Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 130. Capricor Recent Development
Table 131. Cellerant Therapeutics Company Details
Table 132. Cellerant Therapeutics Business Overview
Table 133. Cellerant Therapeutics Product
Table 134. Cellerant Therapeutics Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 135. Cellerant Therapeutics Recent Development
Table 136. Globalstem Company Details
Table 137. Globalstem Business Overview
Table 138. Globalstem Product
Table 139. Globalstem Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 140. Globalstem Recent Development
Table 141. Cellular Dyna Company Details
Table 142. Cellular Dyna Business Overview
Table 143. Cellular Dyna Product
Table 144. Cellular Dyna Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 145. Cellular Dyna Recent Development
Table 146. International Stem Cell Company Details
Table 147. International Stem Cell Business Overview
Table 148. International Stem Cell Product
Table 149. International Stem Cell Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 150. International Stem Cell Recent Development
Table 151. Juventas Therapeutics Company Details
Table 152. Juventas Therapeutics Business Overview
Table 153. Juventas Therapeutics Product
Table 154. Juventas Therapeutics Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 155. Juventas Therapeutics Recent Development
Table 156. Mesoblast Company Details
Table 157. Mesoblast Business Overview
Table 158. Mesoblast Product
Table 159. Mesoblast Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 160. Mesoblast Recent Development
Table 161. Neuralstem Company Details
Table 162. Neuralstem Business Overview
Table 163. Neuralstem Product
Table 164. Neuralstem Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 165. Neuralstem Recent Development
Table 166. Neurogeneration Company Details
Table 167. Neurogeneration Business Overview
Table 168. Neurogeneration Product
Table 169. Neurogeneration Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 170. Neurogeneration Recent Development
Table 171. Ocata Company Details
Table 172. Ocata Business Overview
Table 173. Ocata Product
Table 174. Ocata Revenue in Epithelial Stem Cells Business (2015-2020) (Million US$)
Table 175. Ocata Recent Development
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Epithelial Stem Cells Market Share by Type: 2020 VS 2026
Figure 2. Absorptive Cells Features
Figure 3. Goblet Cell Features
Figure 4. Paneth Cells Features
Figure 5. Oligodendrocytes Features
Figure 6. Global Epithelial Stem Cells Market Share by Application: 2020 VS 2026
Figure 7. Tissue Repair Damage Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. Epithelial Stem Cells Report Years Considered
Figure 11. Global Epithelial Stem Cells Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Epithelial Stem Cells Market Share by Regions: 2020 VS 2026
Figure 13. Global Epithelial Stem Cells Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Epithelial Stem Cells Market Share by Players in 2019
Figure 16. Global Top Epithelial Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epithelial Stem Cells as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Epithelial Stem Cells Revenue in 2019
Figure 18. North America Epithelial Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Epithelial Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Epithelial Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Epithelial Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Epithelial Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Epithelial Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Epithelial Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. 3Dmatrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. 3Dmatrix Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 27. Aldagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Aldagen Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 29. Hybrid Organ Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Hybrid Organ Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 31. Intellicell Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Intellicell Biosciences Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 33. Athersys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Athersys Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 35. Beike Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Beike Biotechnology Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 37. Biotime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Biotime Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 39. Brainstorm Cell Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Brainstorm Cell Therapeutics Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 41. Gamida Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Gamida Cell Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 43. Capricor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Capricor Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 45. Cellerant Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Cellerant Therapeutics Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 47. Globalstem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Globalstem Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 49. Cellular Dyna Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Cellular Dyna Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 51. International Stem Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. International Stem Cell Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 53. Juventas Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Juventas Therapeutics Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 55. Mesoblast Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Mesoblast Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 57. Neuralstem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Neuralstem Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 59. Neurogeneration Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Neurogeneration Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 61. Ocata Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Ocata Revenue Growth Rate in Epithelial Stem Cells Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed